Investment is flowing Big pharma has already noted its interest in the area, as seen in Novartis’ investments ... is Clarity Pharmaceuticals, an Australian company, which is developing ...

Novartis (NVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Steve Scala from ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

"The global regenerative medicine markets comprises of many key market players competing for markets shares like Novartis AG ...

Siemens Healthineers has agreed a €200 million ($224 million) deal to buy the diagnostic arm of Novartis' Advanced ... which are used clinically in products for both diagnosis and therapy.

Australian battery maker Novonix said on Monday it had signed a binding off-take agreement with automaker Stellantis to ...

This partnership aims to enhance the availability and accessibility of AVITA Medical's products to a broader customer base in these regions. "Our collaboration with Revolution Surgical marks the ...

Platinum Asset Management's biotech specialist Dr Bianca Ogden outlines the major opportunities she is seeing in the sector.

The report includes market projections, regulatory information, and updates on new products and technologies. It also ...

After hours: 7 November at 6:28 pm GMT-5 ...